Price Alert

Tekla Life Sciences Inves... (HQL)

NYSE: HQL · Real-Time Price · USD

14.08

0.11 (0.79%)

At close: Aug 21, 2025, 3:59 PM

13.60

-3.41%

Pre-market: Aug 22, 2025, 08:30 AM EDT

Tekla Life Sciences Investors Cash Flow Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q2 2025	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021
Period Ending	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021
Net Income	-47.23M	n/a	n/a	11.18M	33.8M	-52.3K	-52.3K	32.27K	32.27K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	64.75K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Non-Cash Items	46.26M	n/a	n/a	-11.18M	-33.8M	52.3K	52.3K	-32.27K	-32.27K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-73.8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Cash Flow	-1.04M	n/a	n/a	n/a	n/a	n/a	n/a	-0.37	-0.37
Capital Expenditures	-4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-157.46M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	161.84M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	4.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-8.41M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	-8.41M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Cash Flow	n/a	n/a	n/a	32.00	n/a	-545	-545	-0.74	-0.74
Free Cash Flow	-1.04M	n/a	n/a	n/a	n/a	n/a	n/a	-0.37	-0.37